
TRACON Pharmaceuticals Investor Relations Material
Latest events

Q1 2024
TRACON Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from TRACON Pharmaceuticals Inc
Access all reports
TRACON Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing targeted therapies for cancer. The company’s approach includes working with partners to advance drug candidates that address unmet medical needs in oncology. TRACON's pipeline consists of small molecules and biologics designed to treat various cancer types by inhibiting tumor growth and progression. The company also offers its expertise in clinical development and regulatory management to support its collaborations. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
TCON
Country
🇺🇸 United States